Glycolax and Ibrance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glycolax (polyethylene glycol 3350) and Ibrance (palbociclib). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Glycolax and Ibrance. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Glycolax?

Glycolax has active ingredients of polyethylene glycol 3350. eHealthMe is studying from 2,036 Glycolax users. Check the latest studies of Glycolax.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.

On Jul, 03, 2026

19 people who take Glycolax and Ibrance together, and have interactions are studied.

What are the common drug interactions of Glycolax and Ibrance, by gender? *:

female:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Breast mass
Bronchial wall thickening
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Infection
Influenza
Lymphadenopathy (disease or enlargement of lymph nodes)
Lymphangiosis carcinomatosa (inflammation of the lymph vessels can lead to cancer)
Metastases to bone (cancer spreads to bone)

male:

n/a

What are the common drug interactions of Glycolax and Ibrance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arterial injury
Arthralgia (joint pain)
Breast mass
Bronchial wall thickening
Chills (felling of cold)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Fatigue (feeling of tiredness)
Infection
Influenza
Lymphadenopathy (disease or enlargement of lymph nodes)

40-49:

Pulmonary embolism (blockage of the main artery of the lung)
Arterial injury
Breast mass
Bronchial wall thickening
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Infection
Lymphadenopathy (disease or enlargement of lymph nodes)
Lymphangiosis carcinomatosa (inflammation of the lymph vessels can lead to cancer)
Metastases to bone (cancer spreads to bone)
Rib fracture

50-59:

Acute respiratory failure
Constipation
Cough
Dyspepsia (indigestion)
Fatigue (feeling of tiredness)
Hypertension (high blood pressure)
Mucosal haemorrhage (bleeding from mucous membrane)
Muscular weakness (muscle weakness)
Nausea (feeling of having an urge to vomit)
Neoplasm progression (growth of tumour)

60+:

Decreased appetite
Oropharyngeal pain
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Full blood count decreased
Pyrexia (fever)
Abdominal pain
Abdominal pain upper
Back disorder
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)

What are the existing conditions these people have? *

Breast Cancer Female: 7 people, 36.84%
Breast Cancer Metastatic: 5 people, 26.32%
Constipation: 5 people, 26.32%
Nausea (feeling of having an urge to vomit): 4 people, 21.05%
Stress And Anxiety: 3 people, 15.79%
Pain: 3 people, 15.79%
Breast Cancer: 3 people, 15.79%
Nausea And Vomiting: 3 people, 15.79%
Muscle Spasms (muscle contraction): 3 people, 15.79%
Insomnia (sleeplessness): 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Glycolax and Ibrance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously